Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 5 (2) , 326-341
Abstract
No abstract availableKeywords
Funding Information
- Bayer
This publication has 34 references indexed in Scilit:
- Primäre medikamentöse Thromboembolieprophylaxe bei ambulanten Patienten mit fortgeschrittenem Pankreaskarzinom unter Chemotherapie?DMW - Deutsche Medizinische Wochenschrift, 2013
- A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht scoreInternal and Emergency Medicine, 2012
- Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)Journal of Thrombosis and Haemostasis, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Prediction of venous thromboembolism in cancer patientsBlood, 2010
- Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysisJournal of Thrombosis and Haemostasis, 2010
- Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary EmbolismCirculation, 2010
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCanadian Medical Association Journal, 2008
- Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE RegistryThrombosis and Haemostasis, 2008
- Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapyThe American Journal of Medicine, 1989